REMOD, a new AI model, detects pancreatic cancer on CT scans much earlier and more accurately than radiologists.
Key Details
- 1The AI model, REDMOD, was trained to identify radiomic signatures of pre-diagnostic pancreatic ductal adenocarcinoma (PDAC) on CT scans.
- 2It was trained with imaging data from multiple institutions and developed a 40-feature radiomic signature.
- 3Tested on over 200 abdominal CT scans from patients later diagnosed with PDAC despite no initial radiologist findings.
- 4REMOD detected pancreatic cancer on average 475 days before clinical diagnosis.
- 5The model achieved nearly 75% sensitivity, about twice as high as radiologists' sensitivity.
- 6At a 24-month prediction window, REDMOD's sensitivity was triple that of radiologists.
Why It Matters
Early detection of pancreatic cancer is vital due to its poor prognosis when caught late. AI advancements like REDMOD could revolutionize detection efficacy, potentially improving survival rates and demonstrating the impact of imaging AI in clinical practice.
Source
Radiology Business
Related News
•Radiology Business
Aidoc Raises $150M to Expand Imaging AI Portfolio and Global Reach
Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
•AuntMinnie
AI-Driven Mammogram Analysis Boosts Cardiovascular Risk Prediction in Women
AI quantification of breast arterial calcifications (BACs) on mammograms enhances prediction of cardiovascular events beyond traditional risk models.
•AuntMinnie
AI-CAD Boosts Specificity and Efficiency in Asia-Pacific Mammography Study
AI-CAD systems increased specificity and cut interpretation times in a multicenter Asia-Pacific mammography study.